Genie Health
AI health intelligence platform for individuals and healthcare providers to understand and manage health data.
Website: https://geniehealth.care/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | Genie Health |
| Tagline | AI health intelligence platform for individuals and healthcare providers to understand and manage health data. |
| Headquarters | Singapore, Singapore [Singapore Business Times, October 2026] |
| Founded | 2018 [Singapore Business Times, October 2026] |
| Stage | Seed [Singapore Business Times, October 2026] |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | Southeast Asia |
| Growth Profile | Venture Scale |
| Founding Team | Hari V. Krishnan, Maya Hari, Sandeep Suvarna [N Startup, October 2026] |
| Funding Label | Seed |
| Total Disclosed | ~$3,000,000 [Singapore Business Times, October 2026] |
Links
From the public record
- Website: https://geniehealth.care/
- Support: https://geniehealth.care/support
- FAQ: https://geniehealth.care/faq
- Product page: https://geniehealth.care/health-patterns
- Product page: https://geniehealth.care/health-ins
The Short Version
PUBLIC Genie Health is a Singapore-based healthtech startup building an AI health intelligence platform for both individuals and healthcare providers, and it merits investor attention now because it has just announced a US$3 million seed round to expand product capability and push provider adoption [Singapore Business Times, October 2026] [N Startup, October 2026] [geniehealth.care]. The company’s public positioning is straightforward: its consumer-facing Genie product aggregates reports, biomarkers, wearable data, family history, and health context to surface personalized insights, while SmartCare is the clinic-oriented layer intended to help providers work with fragmented patient information more efficiently [geniehealth.care] [CXP - Customer Experience Asia, August 2026].
The founding story, as far as public reporting shows, is anchored in Hari V. Krishnan’s transition from PropertyGuru into healthcare data interpretation, with Genie framed around making scattered medical information more understandable and actionable for non-expert users [Singapore Business Times, October 2026] [The SaaS News, October 2026]. That framing matters because the product differentiation appears to rest less on a general AI claim than on the workflow itself: organizing disparate health records and wearable inputs into a longitudinal view that can generate context-aware patterns and nudges, then extending that system into clinics through SmartCare [geniehealth.care] [Signalbase, October 2026].
The team is one of the stronger signals in the file. Hari V. Krishnan previously led PropertyGuru through major financings and toward IPO-era scale, while Maya Hari’s public background includes senior strategy and operating roles at Twitter, giving Genie a founding bench with prior large-platform operating experience that is unusual for a seed-stage regional healthtech company [TechCrunch, September 2020] [TechCrunch, October 2018] [Bloomberg Markets]. Public sources also name Sandeep Suvarna as a co-founder, and ZoomInfo identifies him as co-founder and chief marketing officer, though operating scope beyond that remains only partially corroborated in the public record [N Startup, October 2026] [ZoomInfo].
On financing, the key public fact is the October 2026 seed round led by Nadathur Family Office with participation from Liminal, with coverage consistently describing the company as seed stage and positioning the model as serving both consumers and providers, which supports a B2B2C reading [Singapore Business Times, October 2026] [Singapore Business Review, October 2026] [The SaaS News, October 2026]. Over the next 12 to 18 months, the main points to watch are whether SmartCare converts from product narrative into named clinic adoption, whether the company can evidence repeatable engagement beyond the initial health-data aggregation use case, and whether hiring in marketing and AI engineering translates into measurable distribution and product depth [geniehealth.care] [Singapore Business Review, October 2026].
Single-source, plausible -- Core funding and founder-background claims are corroborated by multiple public sources, but material product detail is still heavily reliant on company materials.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | Southeast Asia |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | Total disclosed approximately US$3 million [Singapore Business Times, October 2026] |
The Company in Brief
PUBLIC
Genie Health enters the public record with a fairly simple proposition: it is building a health intelligence platform for both individuals and healthcare providers, and the company is doing so from Singapore [geniehealth.care]. The company website describes Genie Health as a platform serving consumers through Genie and providers through Genie SmartCare, while its pages frame the product around organizing reports, biomarkers, wearable data, family history, and health events into a single context layer for more personalized guidance [geniehealth.care].
The chronology that can be stated cleanly from the available company-grounded record is narrow but still useful. Krishnan, Maya Hari, and Sandeep Suvarna [geniehealth.care]. More recently, Genie Health announced a US$3 million seed round in October 2026, which the company said would be used to grow its health intelligence platform [geniehealth.care].
There is less public precision on corporate structure than on product positioning. A specific legal entity name does not appear in the supplied company-site materials, so the public view is stronger on operating narrative than on registration detail [geniehealth.care]. Even so, the combination of a Singapore headquarters, a dual-sided consumer and provider product surface, and a newly disclosed seed round gives a workable baseline for investors assessing whether the company is moving from concept framing into institutional buildout [geniehealth.care].
Unconfirmed -- This section relies primarily on company website materials, with no cited state filing or Crunchbase corroboration in the provided source set.
What They Have Built
MIXED
The product surface is straightforward in concept, even if the underlying clinical workflow is still only lightly documented in public. Genie Health presents itself as a health intelligence platform for individuals and healthcare providers, with a consumer-facing Genie product and a provider-facing Genie SmartCare product [geniehealth.care] [Singapore Business Times, October 2026]. On its website, the company says the platform brings together reports, biomarkers, family history, wearable data, and broader health context to generate personalized health insights and surface patterns across a user’s health timeline [geniehealth.care].
Press coverage adds a little more color on the provider side, though most of the capability claims still trace back to the company. CXP described Genie as helping individuals organize, understand, and manage health information, while describing SmartCare as an agentic AI platform for healthcare providers that automates patient engagement and turns fragmented health data into actionable clinical insights [CXP - Customer Experience Asia, August 2026]. The company website also says SmartCare offers custom pricing for multi-location teams and higher volumes, includes customer support, and is built with a privacy-first architecture aligned with health data standards including Singapore PDPA [geniehealth.care].
The clearest public signal on technical implementation comes indirectly through hiring. A Principal Full Stack and AI Engineer role cited responsibilities spanning document ingestion, clinical NLP, pattern detection, personalized insight generation, mobile and web applications, and cloud infrastructure, which supports an inference that the product stack combines data ingestion, model-driven interpretation, and end-user application layers (inferred from job postings) [geniehealth.care] [PERPLEXITY SONAR PRO BRIEF]. That said, there is no verified public demo, no published deployment architecture, and no disclosed performance data on accuracy, clinical outcomes, or provider workflow savings in the materials reviewed [Singapore Business Review, October 2026] [N Startup, October 2026].
Unconfirmed -- Product positioning is supported by the company website and repeated in press coverage, but the underlying capability detail remains primarily company-described, with technical inferences drawn from job postings.
Market Size and Demand
From the public record
This market matters now because consumer health data is fragmenting across labs, wearables, imaging, clinics, and family history, while providers are under separate pressure to turn that sprawl into usable context without adding more manual work, a combination that creates room for software that organizes and interprets health information rather than merely storing it [geniehealth.care] [CXP - Customer Experience Asia, August 2026] [Singapore Business Times, October 2026].
The constraint in sizing Genie Health's addressable market is straightforward: the available source set does not include a named third-party TAM, SAM, or SOM study tied directly to AI health intelligence platforms in Southeast Asia. Public evidence supports the product's target surfaces, individuals managing complex health information and healthcare providers using the SmartCare workflow, but not a verified market size for either segment in this specific geography [geniehealth.care] [N Startup, October 2026] [Singapore Business Review, October 2026]. In practice, that leaves the market case resting less on a clean category definition and more on adjacent software budgets in digital health, patient engagement, and clinical data summarization, all of which are plausible analogues rather than confirmed sizing evidence for Genie itself [CXP - Customer Experience Asia, August 2026].
Demand signals are clearer than market size. Genie describes its core user problem as connecting reports, biomarkers, wearable data, family history, and timeline data to surface patterns and personalized insights, which maps to a broader shift toward longitudinal consumer health records rather than single-visit snapshots [geniehealth.care]. On the provider side, public descriptions of SmartCare emphasize patient engagement and converting fragmented data into actionable clinical insight, suggesting that the nearer-term commercial wedge may be workflow efficiency and better patient context inside clinics, not pure consumer subscription demand [CXP - Customer Experience Asia, August 2026] [AOL]. The company's October 2026 financing was also framed around accelerating provider adoption and building AI capabilities, a useful clue on where management sees demand concentration today [Singapore Business Times, October 2026] [Singapore Business Review, October 2026].
The closest adjacent markets are easier to define than the exact one Genie is trying to build. One adjacency is personal health record and consumer wellness software, where the value proposition centers on aggregating data from reports and devices into a single view [geniehealth.care]. Another is clinic software for patient communication, intake, and follow-up, where SmartCare appears positioned as an intelligence layer rather than a full system of record [geniehealth.care] [CXP - Customer Experience Asia, August 2026]. A third substitute market is the status quo itself: patients manually collecting PDFs and lab results, and providers relying on fragmented records and intake conversations. If Genie can reduce that friction, it is competing partly against existing software categories and partly against non-consumption.
Regulation is likely to shape adoption as much as product quality. The company states that SmartCare uses a privacy-first architecture aligned with Singapore's Personal Data Protection Act, which is a necessary baseline in a category built on sensitive health information, though public sources do not provide independent certification details or implementation specifics [geniehealth.care]. More broadly, any company aggregating medical records and wearable data will face enterprise scrutiny on consent, storage, model behavior, and clinical workflow boundaries. That does not block the category, but it usually lengthens sales cycles and raises the standard for trust, especially when the product claims to generate insights rather than simply archive data [geniehealth.care] [Singapore Business Times, October 2026].
| Market lens | Public evidence | Relevance to Genie |
|---|---|---|
| Consumer health data aggregation | Genie positions its consumer product around combining reports, biomarkers, wearable data, family history, and timeline data into one view [geniehealth.care] | Supports an individual-facing market anchored in data organization and interpretation |
| Provider patient-engagement software | SmartCare is described as a provider-focused platform for patient engagement and actionable clinical insights [CXP - Customer Experience Asia, August 2026] [AOL] | Suggests the commercial entry point may sit closer to clinic workflow budgets than pure consumer spend |
| Health data compliance and trust infrastructure | SmartCare is described by the company as privacy-first and aligned with Singapore PDPA [geniehealth.care] | Indicates compliance is part of category formation, procurement, and adoption risk |
The evidence supports a real problem area and a credible set of adjacent software budgets, but not a precise, independently sourced market size for this exact category. For now, the market case is strongest when framed as convergence across consumer health organization, provider engagement tooling, and data interpretation, rather than as a neatly bounded standalone market.
Single-source, plausible -- Based primarily on company materials and a limited set of named publisher funding and product descriptions; no independent third-party market sizing report was available in the provided sources.
Who Else Is Fighting for This
MIXED Genie Health is positioning itself less against a single named startup than against the default way health data is handled today: scattered across clinic systems, PDFs, lab reports, and consumer wearables, with interpretation still mediated by provider time and patient effort [geniehealth.care] [CXP - Customer Experience Asia, August 2026] [Singapore Business Times, October 2026].
The competitive map is clearer by segment than by logo. On one side sit healthcare incumbents, meaning clinic software, hospital records systems, and the workflows that already store pieces of the patient record; those systems benefit from existing provider relationships and embedded operational use, but the cited public material here does not show them delivering the consumer-facing synthesis Genie describes across reports, biomarkers, wearables, family history, and a personal health timeline [geniehealth.care] [geniehealth.care, Discover Patterns Across Your Health Data]. On another side are consumer substitutes, which include manual record keeping, general wellness apps, and the clinician visit itself as the moment when fragmented information is interpreted; those substitutes are familiar and cheap in the short run, but they tend to break when the user needs longitudinal context across multiple data types [geniehealth.care] [The SaaS News, October 2026].
Genie’s edge, based on public evidence, appears to rest on product framing and founder signal rather than proven distribution. The company presents one stack serving both individuals and providers, with Genie for personal use and SmartCare for clinics, which could matter if a shared data model improves onboarding or insight quality across both sides of the market [geniehealth.care] [geniehealth.care, Genie SmartCare: Clinic intelligence platform powered by AI] [N Startup, October 2026]. The founder profile is also commercially relevant: Hari V. Krishnan previously led PropertyGuru, and Maya Hari held senior strategy and operating roles at Twitter, which gives Genie an unusual level of executive pattern recognition for a seed-stage Southeast Asia healthtech company [Bloomberg Markets] [TechCrunch, September 2020] [Bloomberg, November 2019]. That edge is still perishable. Public sources confirm a seed round and hiring plans, but they do not yet confirm customer logos, deployment scale, or a channel partner base that would make the position hard for better-distributed healthcare software vendors to copy [Singapore Business Times, October 2026] [Singapore Business Review, October 2026].
The exposure is easier to identify than the moat. Genie does not appear, from the cited public material, to own a provider channel, a regulated data network, or a proprietary installed base inside clinics, which means it may face resistance from systems that are already the operational system of record even if those systems are weaker at patient-facing interpretation [geniehealth.care] [CXP - Customer Experience Asia, August 2026]. It is also exposed to adjacency from large consumer platforms and wearables ecosystems that already collect part of the data exhaust Genie wants to organize, even if the current sources do not establish those firms as direct entrants into Genie’s exact workflow. SmartCare’s privacy-first positioning and reference to Singapore PDPA alignment are directionally helpful, but compliance language on a company site is not the same as market power or procurement clearance at scale [geniehealth.care, Genie SmartCare: Clinic intelligence platform powered by AI].
Over the next 18 months, the most plausible competitive scenario is a race between workflow adoption and feature replication. Genie is the likely winner if clinic adoption of SmartCare converts into repeat provider usage and gives the company a steady stream of longitudinal data and patient engagement touchpoints, because that would move it from a useful overlay into part of the care workflow [Singapore Business Times, October 2026] [N Startup, October 2026]. Genie is the likely loser if incumbent clinic software vendors or broader health platforms add comparable document ingestion and insight generation before Genie secures meaningful distribution, because the current public record shows concept and funding, not yet entrenched market access [Singapore Business Review, October 2026] [The SaaS News, October 2026].
Single-source, plausible -- Public reporting supports the company positioning, founder background, and seed financing, but direct named competitors and market share evidence are not present in the cited sources.
Opportunity
From the public record The prize here is not a better wellness app, it is the chance to become a trusted operating layer for fragmented personal and clinical health data in Southeast Asia, a market where patients and providers still manage too much information across disconnected reports, biomarkers, and wearable streams [geniehealth.care] [Singapore Business Times, October 2026].
The headline opportunity is straightforward. If Genie Health can turn scattered health records into a usable longitudinal intelligence layer for both consumers and clinics, it could occupy a valuable middle position between patient-facing engagement tools and provider workflows [geniehealth.care] [CXP - Customer Experience Asia, August 2026]. That outcome is still early, but it is not purely aspirational. Public materials show the company is already positioning the same core data problem across two buying centers, individuals through Genie and providers through SmartCare, while the October 2026 seed round gives it capital to improve AI capabilities, accelerate provider adoption, and hire across product and engineering [geniehealth.care, October 2026] [Singapore Business Times, October 2026] [Singapore Business Review, October 2026]. The founding team also matters here. Hari V. Krishnan previously led PropertyGuru through multiple large financings and toward IPO, which does not validate clinical execution, but does support the view that Genie has experienced operators behind an unusually ambitious regional buildout [TechCrunch, September 2020] [TechCrunch, October 2018] [Bloomberg Markets].
The upside paths are still few and legible at this stage, which is preferable to a company claiming ten wedges at once.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Consumer record layer | Genie becomes a high-trust personal health record and insight layer for affluent, data-rich users who already collect reports and wearable data, then monetizes through recurring subscriptions or care navigation extensions | Better personalization from combining medical documents, biomarkers, family history, and wearables into one timeline | The product is already described as connecting reports, biomarkers, wearable data, family history, and health timeline data to surface patterns and personalized insights [geniehealth.care] [Signalbase, October 2026] |
| Clinic workflow wedge | SmartCare wins initial clinic adoption as a way to automate patient engagement and organize fragmented patient information, then expands from point solution to system of intelligence inside outpatient settings | Successful deployment of SmartCare as a provider-facing AI layer with privacy and workflow credibility | SmartCare is publicly positioned for healthcare providers, with custom pricing for multi-location teams, customer support, and alignment with Singapore PDPA cited on the company site; outside coverage also describes it as a platform for patient engagement and clinical insights [geniehealth.care] [CXP - Customer Experience Asia, August 2026] [AOL] |
| B2B2C bridge model | Genie uses provider distribution to acquire end users at lower cost, while consumer engagement improves the usefulness of the provider product | Clinics adopt SmartCare and steer patients into Genie, creating a shared data loop across both products | The company explicitly serves both individuals and healthcare providers, and its funding announcement says proceeds will support faster SmartCare adoption and broader platform development, which is consistent with a two-sided expansion strategy [geniehealth.care] [Singapore Business Times, October 2026] [N Startup, October 2026] |
What compounding looks like is less about classic social network effects and more about data density, trust, and distribution efficiency. Each additional user who consolidates reports, biomarkers, family history, and wearable data makes the product more useful at the point of insight generation, because the system has more context to identify patterns across time [geniehealth.care]. Each clinic that adopts SmartCare could also make consumer acquisition cheaper if patients are introduced to Genie through a provider relationship rather than through paid marketing. That logic is not proven publicly, but it fits the company's stated B2B2C posture and the fact that one of its visible open roles is a Growth & Product Marketing Manager, while the other is a Principal Full Stack and AI Engineer focused on ingestion, clinical NLP, pattern detection, and insight generation [geniehealth.care] [N Startup, October 2026]. In other words, the early build appears aimed at both better intelligence and lower-friction distribution.
The size of the win is best framed through scenario logic rather than unsupported market sizing. A credible public comparable or category TAM was not established in the cited source set, so attaching a hard valuation range would overstate precision. Still, if Genie were to become a regional default intelligence layer for consumer-controlled health data and clinic-side engagement workflows, the company could plausibly grow into a strategic asset with platform value well beyond a narrow single-product health app, particularly because healthcare data systems tend to reward trust, retention, and workflow embedding once adoption takes hold (scenario, not a forecast) [Singapore Business Times, October 2026] [geniehealth.care]. The evidence available today supports the existence of a real wedge and a founder-market narrative that investors have already funded. What it does not yet support, publicly, is the magnitude of adoption required to underwrite that outcome.
Unconfirmed -- This section relies materially on company website product descriptions and company-announced use of proceeds, with partial corroboration from funding coverage and founder background sources [geniehealth.care] [Singapore Business Times, October 2026] [Singapore Business Review, October 2026] [TechCrunch, September 2020].
Sources
From the public record
[Singapore Business Times, October 2026] PropertyGuru ex-CEO’s AI health startup Genie Health raises US$3 million in seed funding | https://www.businesstimes.com.sg/startups-tech/startups/propertyguru-ex-ceos-ai-health-startup-genie-health-raises-us3-million-seed-funding
[N Startup, October 2026] Genie Health Raises $3M to Expand Its AI-Powered Health Platforms | https://nstartup.me/news/8bf96529-da71-4f61-bb1d-c4f832fe904a
[geniehealth.care] Genie Health | Health Intelligence for everyone | Genie | https://geniehealth.care/
[CXP - Customer Experience Asia, August 2026] Genie Health launches SmartCare to bring agentic AI to healthcare providers | https://cxp.asia/articles/genie-health-launches-smartcare-to-bring-agentic-ai-to-healthcare-providers/
[The SaaS News, October 2026] Genie Health Raises $3M Seed | https://www.thesaasnews.com/news/genie-health-raises-3m-seed/
[Signalbase, October 2026] Genie Health Raises $3.0M Seed Round | https://www.trysignalbase.com/news/funding/genie-health-raises-3m-seed-round
[TechCrunch, September 2020] PropertyGuru lands $220M from KKR and TPG to conquer Southeast Asia | https://techcrunch.com/2020/09/02/propertyguru-220m-funding-kkr-tpg/
[TechCrunch, October 2018] KKR's latest Southeast Asia bet is a $144M investment in PropertyGuru | https://techcrunch.com/2018/10/31/propertyguru-kkr-144-million/
[Bloomberg Markets] Hari V Krishnan, PropertyGuru Group Limited: Profile and Biography | https://www.bloomberg.com/profile/person/18033129
[Singapore Business Review, October 2026] Genie Health raises $3.8m to scale AI health platform | https://sbr.com.sg/healthcare/news/genie-health-raises-38m-scale-ai-health-platform
[ZoomInfo] Contact Sandeep Suvarna, Email: ****@genie.health & Phone Number | Co-Founder & Chief Marketing Officer at Genie Health | https://www.zoominfo.com/p/Sandeep-Suvarna/-
[AOL] Genie SmartCare is a provider-focused agentic AI platform designed to transform patient engagement and health information into meaningful intelligence | https://www.aol.com/
[Bloomberg, November 2019] Watch Sustainability, Climate Change, Fintech Discussed by Maya Hari, Twitter APAC VP & Managing Director | https://www.bloomberg.com/news/videos/2019-11-11/watch-sustainability-climate-change-fintech-discussed-by-maya-hari-twitter-apac-vp-managing-director-video
[geniehealth.care, October 2026] Genie Health closes a US$3 million seed round to grow its health intelligence platform | https://geniehealth.care/media/genie-health-us3-million-seed-funding
[geniehealth.care, Discover Patterns Across Your Health Data] Discover Patterns Across Your Health Data | Genie Health | https://geniehealth.care/health-patterns
[geniehealth.care, Genie SmartCare: Clinic intelligence platform powered by AI] Genie SmartCare: Clinic intelligence platform powered by AI | https://geniehealth.care/smartcare
Articles about Genie Health
- Genie Health Raises $3 Million to Wire AI Into Singapore’s Clinics — The Singapore-based startup, led by a former PropertyGuru CEO, is using a $3 million seed round to push its provider-facing platform as the wedge into a fragmented market.